It is an anticoagulant agent acting both in vivo and in vitro. Literature indicates some possible advantages of Calcium Heparin, over Sodium Salt, in half-life and undesirable vascular reactions at the site of injection. Its main uses are in treatment and prophylaxis of thrombogenic states.It solutions for intravenous or subcutaneous injection in ampoules, vials or pre-filled siringes.
The Calcium Heparin market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Calcium Heparin market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Calcium Heparin market.

Major Players in the Calcium Heparin market are:
Deebio
CSBIO
GSK
elephantcare
BioibéricaSAU
Zhaoke Pharma
Jiulong Biochemicals
CHASE SUN
Dongcheng Biochemicals
Pfizer
Techpool
Opocrin
Yino Pharma Limited
Kingfriend
Changlong Pharma
Hepatunn
Aspen Pharma

On the basis of types, the Calcium Heparin market is primarily split into:
Heparin Sodium
Heparin Calcium

On the basis of applications, the market covers:
Unfractionated Heparin
Low Molecular Heparin API

Major Region

s or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years:

2017-2021

Base Year:

2021

Estimated Year:

2022

Forecast Period:

2022-2029